Total Funding
70
1
Total FundingPost-IPO Equity raised
Growth Score
-7 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3746193
Innovation Pharmaceuticals is a biopharmaceutical company developing small molecule therapies in areas of unmet medical needs.
Krishna Menon: President, Chief Scientific OfficerPast Role: Eli Lilly, Group Leader, Cancer In Vivo Research and Clinical Development
Leo Ehrlich: Co-Founder, Chief Executive Officer, Chief Financial Officer; Board Chairman
About the Company
Innovation Pharmaceuticals is a publicly traded biopharmaceutical company dedicated to discovering and advancing innovative medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications.
